Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Distribution

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...

Pharmacokinetics in Pediatric Patients: Drug Excretion

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Assessing the real-world effects of prophylactic hydrocortisone in the Canadian Neonatal Network: A cohort study.

Journal of perinatology : official journal of the California Perinatal Association·2026

Same author

Predicting bronchopulmonary dysplasia is complicated (as it should be): toward a framework for integrating physiological data.

Pediatric research·2026

Same author

Variation in Stabilization and Resuscitation Practices at Birth of Preterm Infants Among 12 National or Regional Neonatal Networks.

Acta paediatrica (Oslo, Norway : 1992)·2026

Same author

Prospective MRI Assessment of Early Myelination Over the First Month of Life in Neonates With Neonatal Hypoxic-Ischemic Encephalopathy Treated With Therapeutic Hypothermia With or Without Sildenafil.

AJNR. American journal of neuroradiology·2026

Same author

Pharmacologic Therapies for Patent Ductus Arteriosus in Extremely Preterm Infants.

JAMA network open·2026

Same author

Respiratory trajectories of infants born before 26 weeks of gestation from birth to discharge: an exploratory analysis of a randomised controlled trial.

The Lancet. Child & adolescent health·2026

Same journal

Precision Proteomic Profiling of Systemic Lupus Erythematosus-Correlating Disease Activity and Complement Levels with Clinical Phenotypes.

Biomedicines·2026

Same journal

The Role of Salivary Microbiota in Pancreatic Cancer: From Screening to Tumor Progression and Treatment Response.

Biomedicines·2026

Same journal

Diagnostic Utility of Surface Electromyography for Identifying Muscles Affected by Myofascial Trigger Points: A Scoping Review.

Biomedicines·2026

Same journal

Performance Assessment of a Locally Semi-Automated NGS-Based Workflow for Homologous Recombination Deficiency Testing in High-Grade Serous Ovarian Carcinoma.

Biomedicines·2026

Same journal

Coupling and Uncoupling Pleiotropy Between Hypertension and Type 2 Diabetes Contribute to Exploring Potential Heterogeneity in Cardiovascular Risk in East Asian Population.

Biomedicines·2026

Same journal

Maternal Response to Therapeutic Plasma Exchange in Early Gestation: A Case Series of Thrombotic Microangiopathies and Neurological Disorders.

Biomedicines·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Jun 29, 2026

Mouse Models of Periventricular Leukomalacia

Mouse Models of Periventricular Leukomalacia

Published on: May 18, 2010

PDA in Prematurity: Rethinking a Decades-Old Debate in 2026.

Phoenix Plessas-Azurduy¹, Anie Lapointe², Sarah Spénard³

¹Division of Clinical & Translational Research, Department of Medicine, McGill University, Montreal Children's Hospital, Montréal, QC H4A 3H9, Canada.

|March 28, 2026

Summary

This summary is machine-generated.

Managing patent ductus arteriosus (PDA) in premature infants with drugs or surgery shows limited benefits and risks. A conservative approach focusing on supportive care may be safer and more effective for these vulnerable infants.

Keywords:

acetaminophen bronchopulmonary dysplasia expectant management neonatal outcomes nonsteroidal anti-inflammatory drugs patent ductus arteriosus pharmacological closure postnatal corticosteroids prematurity

More Related Videos

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats

Published on: November 20, 2015

A Rat Model of Mild Intrauterine Hypoperfusion with Microcoil Stenosis

A Rat Model of Mild Intrauterine Hypoperfusion with Microcoil Stenosis

Published on: January 7, 2018

Related Experiment Videos

Last Updated: Jun 29, 2026

Mouse Models of Periventricular Leukomalacia

Mouse Models of Periventricular Leukomalacia

Published on: May 18, 2010

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats

Published on: November 20, 2015

A Rat Model of Mild Intrauterine Hypoperfusion with Microcoil Stenosis

A Rat Model of Mild Intrauterine Hypoperfusion with Microcoil Stenosis

Published on: January 7, 2018

Area of Science:

Neonatology
Perinatal Medicine
Pediatric Cardiology

Background:

Patent ductus arteriosus (PDA) management in preterm infants is controversial.
Current interventions (NSAIDs, acetaminophen, surgery) have risks and questionable efficacy.
Recent evidence questions the benefits of early PDA treatment.

Purpose of the Study:

To evaluate the efficacy and safety of current PDA management strategies.
To explore the potential benefits of a conservative management approach.
To inform clinical practice regarding PDA in preterm neonates.

Main Methods:

Review of recent randomized controlled trials (RCTs) and meta-analyses.
Analysis of data on pharmacological and procedural PDA closure methods.
Assessment of clinical outcomes including mortality, BPD, IVH, and NEC.

Main Results:

Pharmacological PDA closure has limited efficacy and significant systemic toxicity.
Early active treatment does not improve key clinical outcomes and may increase harm.
Procedural methods achieve anatomical closure but lack proven clinical outcome benefits.
Spontaneous PDA closure is common, especially in extremely preterm infants.

Conclusions:

A paradigm shift towards expectant or conservative management for PDA is warranted.
Supportive care and minimizing interventions may be optimal.
Postnatal corticosteroids might aid closure in select infants with lung disease.